141 related articles for article (PubMed ID: 2753050)
21. Hexakis(carbomethoxyisopropylisonitrile) technetium(I), a new myocardial perfusion imaging agent: binding characteristics in cultured chick heart cells.
Piwnica-Worms D; Kronauge JF; Holman BL; Lister-James J; Davison A; Jones AG
J Nucl Med; 1988 Jan; 29(1):55-61. PubMed ID: 3335928
[TBL] [Abstract][Full Text] [Related]
22. Myocardial uptake of (99m)Tc-N-NOET and (201)Tl during dobutamine infusion. Comparison with adenosine stress.
Calnon DA; Ruiz M; Vanzetto G; Watson DD; Beller GA; Glover DK
Circulation; 1999 Oct; 100(15):1653-9. PubMed ID: 10517738
[TBL] [Abstract][Full Text] [Related]
23. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.
Kinuya S; Yokoyama K; Li XF; Bai J; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1006-11. PubMed ID: 12173013
[TBL] [Abstract][Full Text] [Related]
25. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
Arbab AS; Koizumi K; Toyama K; Araki T
J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217
[TBL] [Abstract][Full Text] [Related]
26. New agents labelled with technetium 99m for myocardial perfusion imaging.
Taillefer R
Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
[TBL] [Abstract][Full Text] [Related]
27. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201.
Sinusas AJ; Watson DD; Cannon JM; Beller GA
J Am Coll Cardiol; 1989 Dec; 14(7):1785-93. PubMed ID: 2584570
[TBL] [Abstract][Full Text] [Related]
28. Experimental studies of the physiologic properties of technetium-99m isonitriles.
Beller GA; Sinusas AJ
Am J Cardiol; 1990 Oct; 66(13):5E-8E. PubMed ID: 2145747
[TBL] [Abstract][Full Text] [Related]
29. Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells.
Piwnica-Worms D; Kronauge JF; Chiu ML
J Nucl Med; 1991 Oct; 32(10):1992-9. PubMed ID: 1919744
[TBL] [Abstract][Full Text] [Related]
30. Effects of ouabain on technetium-99m-Q12 and thallium-201 extraction and retention by isolated rat heart.
McGoron AJ; Gerson MC; Biniakiewicz DS; Washburn LC; Millard RW
J Nucl Med; 1996 May; 37(5):752-6. PubMed ID: 8965140
[TBL] [Abstract][Full Text] [Related]
31. [Effects of ouabain on 201Tl and 99mTc MIBI kinetics in rat myocardium--in vivo study using miniature CsI detector].
Tange S
Kaku Igaku; 1992 Aug; 29(8):963-70. PubMed ID: 1331578
[TBL] [Abstract][Full Text] [Related]
32. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
Berman DS; Kiat H; Maddahi J
Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
[TBL] [Abstract][Full Text] [Related]
33. Myocardial perfusion imaging with technetium-99m-labeled agents.
Maddahi J; Kiat H; Berman DS
Am J Cardiol; 1991 May; 67(14):27D-34D. PubMed ID: 1827941
[TBL] [Abstract][Full Text] [Related]
34. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M
J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353
[TBL] [Abstract][Full Text] [Related]
35. Myocardial perfusion imaging with a new radiotracer, technetium-99m-hexamibi (methoxy isobutyl isonitrile): comparison with thallium-201 imaging.
Taillefer R; Dupras G; Sporn V; Rigo P; Leveille J; Boucher P; Perez-Balino N; Camin LL; McKusick KA
Clin Nucl Med; 1989 Feb; 14(2):89-96. PubMed ID: 2731400
[TBL] [Abstract][Full Text] [Related]
36. Introduction--Technetium-99m myocardial perfusion imaging agents and their relation to thallium-201.
Berman DS
Am J Cardiol; 1990 Oct; 66(13):1E-4E. PubMed ID: 1977298
[No Abstract] [Full Text] [Related]
37. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
[TBL] [Abstract][Full Text] [Related]
38. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
[TBL] [Abstract][Full Text] [Related]
39. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
Bonow RO; Dilsizian V
J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
[No Abstract] [Full Text] [Related]
40. Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging.
Goethals LR; Santos I; Caveliers V; Paulo A; De Geeter F; Lurdes PG; Fernandes C; Lahoutte T
Contrast Media Mol Imaging; 2011; 6(4):178-88. PubMed ID: 21861278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
